About us
Empowering new therapeutics with advanced antibody discovery technologies
At AbTherx, we are redefining therapeutic antibody discovery. We are driven by our passion for creating best-in-class therapeutics by advancing reliable, scalable transgenic technologies grounded in rigorous science.
Our Atlas™ Mouse platform is built on two decades of experience and utilizes evolutionary intelligence to identify diverse and developable human antibody sequences. We enable the discovery and development of monoclonal and bispecific antibodies against diverse targets, including GPCRs and ion channels, unlocking previously inaccessible therapeutic opportunities and providing drug developers with powerful new technologies.
Beyond engineering Atlas Mice for unmatched performance, we offer flexible partnership models—from standard licensing terms to milestone- and royalty-free structures—tailored to the needs of drug developers. Whether you’re a biotech startup or a global pharmaceutical leader, AbTherx provides the technologies and collaborative expertise to drive innovation.